Home/DiaSorin/Francesco Soro
FS

Francesco Soro

Chief Financial Officer

DiaSorin

DiaSorin Pipeline

DrugIndicationPhase
LIAISON® MeMed BV®Bacterial vs. Viral Infection DifferentiationCommercial
LIAISON® CalprotectinInflammatory Bowel Disease (IBD)Commercial
MUREX Anti-HDVHepatitis D Virus DetectionCommercial
QuantiFERON®-TB Gold PlusTuberculosis InfectionCommercial
Expanded Respiratory Panels (xMAP)Syndromic Respiratory InfectionsDevelopment
LIAISON® PLEX AssaysMultiplex ImmunoassaysDevelopment
Next-Gen High-Throughput AnalyzerPlatform InnovationR&D